Quarterly report pursuant to Section 13 or 15(d)

Discontinued Operations - Schedule of Discontinued Operation of Balance Sheet and Operation Statement (Details)

v3.19.3.a.u2
Discontinued Operations - Schedule of Discontinued Operation of Balance Sheet and Operation Statement (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Dec. 31, 2018
Cash $ 5,369   $ 5,369   $ 6,994
Accounts receivable, net 293,906   293,906   97,581
Prepaid expenses and other current assets 6,867   6,867   35,777
Current assets classified as held for sale 306,142   306,142   140,352
Property and equipment, net 6,683   6,683   5,790
Deposits 6,029   6,029   6,029
Non-current assets classified as held for sale 12,712   12,712   11,819
Accounts payable (includes related parties) 1,182,865   1,182,865   1,079,827
Accrued expenses 1,164,410   1,164,410   939,183
Current portion of notes payable 270,737   270,737   278,836
Current liabilities classified as held for sale 2,618,012   2,618,012   2,297,846
Revenue from services 376,880 $ 486,614 519,951 $ 870,812  
Cost of services 38,409 37,740 87,254 88,097  
Gross profit 338,471 448,874 432,697 782,715  
Operating expenses 480,720 605,272 1,057,595 1,315,040  
Other expense (income) 3,002 (9,821) 28,962 (807,541)  
Provision for income taxes  
Loss from discontinued operations (145,251) (146,577) (653,860) 275,216  
Advanced Molecular Services Group [Member]          
Cash 220   220   4,471
Accounts receivable, net 27,321   27,321   6,838
Prepaid expenses and other current assets     25,477
Current assets classified as held for sale 27,541   27,541   36,786
Non-current assets classified as held for sale    
Accounts payable (includes related parties) 533,856   533,856   532,858
Accrued expenses 478,119   478,119   418,932
Current portion of notes payable 270,737   270,737   278,836
Current liabilities classified as held for sale 1,282,712   1,282,712   1,230,626
Non-current liabilities classified as held for sale    
Revenue from services 25,500 45,156 48,482 78,841  
Cost of services 7,105 6,075 23,760 22,214  
Gross profit 18,395 39,080 24,722 56,627  
Operating expenses 74,008 94,683 176,618 270,885  
Other expense (income) 3,002 (13,313) 28,962 (813,510)  
Provision for income taxes  
Loss from discontinued operations (58,615) (42,290) (180,858) 599,252  
Health Technology Solutions, Inc [Member]          
Cash 5,149   5,149   2,523
Accounts receivable, net 266,585   266,585   90,743
Prepaid expenses and other current assets 6,867   6,867   10,300
Current assets classified as held for sale 278,601   278,601   103,566
Property and equipment, net 6,683   6,683   5,790
Deposits 6,029   6,029   6,029
Non-current assets classified as held for sale 12,712   12,712   11,819
Accounts payable (includes related parties) 649,009   649,009   546,969
Accrued expenses 686,291   686,291   520,251
Current portion of notes payable    
Current liabilities classified as held for sale 1,335,300   1,335,300   $ 1,067,220
Revenue from services 351,380 441,458 471,469 791,971  
Cost of services 31,304 31,665 63,494 65,883  
Gross profit 320,076 409,793 407,975 726,088  
Operating expenses 406,712 510,589 880,977 1,044,155  
Other expense (income) 3,491 5,969  
Provision for income taxes  
Loss from discontinued operations $ (86,636) $ (104,287) $ (473,002) $ (324,036)